Pharma giants like Cipla, Glenmark, and Emcure are stepping into the booming skincare market, challenging beauty brands with science-backed products as consumers increasingly seek efficacy over hype. But currently, they are only a patch on the overall beauty and personal care market.
5 min read16 Jul 2025A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring to U.S. biopharma.
4 min read16 Jul 2025The company has plans to make further acquisitions to enter newer product segments and geographies and expand market share.
4 min read16 Jul 2025Anthem Biosciences’ IPO puts the spotlight on India’s contract drug manufacturing sector, as investor appetite swells and global firms diversify away from China.
3 min read15 Jul 2025Sun recieved approval from the US Food and Drug Administration for Leqselvi in July 2024. Soon after the regulator’s approval, Incyte Corporation filed a patent infringement lawsuit against Sun Pharma, alleging that Leqselvi infringed upon its existing patents.
2 min read14 Jul 2025Glenmark’s outlicensing deal with AbbVie for a novel drug for blood cancer under development sets a new course for the company and the Indian pharmaceutical industry.
4 min read14 Jul 2025Stocks to buy for the short term: The Indian stock market remains under pressure as Trump's tariff announcement affects investor sentiment. The Nifty 50 index struggles to breach resistance levels, with key support at 25,000.
3 min read14 Jul 2025Glenmark’s progress with a cancer treatment shows the potential of Indian pharma to move from generics to drug discovery. With tech-enabled therapies evolving fast, new inflection points spell a variety of opportunities for startups and established players to leap ahead.
2 min read14 Jul 2025The online process could hurt pharma exports, Pharmexcil said, even as drugmakers face slower approvals and increased scrutiny in foreign markets.
2 min read11 Jul 2025As part of the strategic realignment of its US business, the company has filed for voluntary liquidation under Chapter 7 of the US Bankruptcy Code for its US step down subsidiaries, Morton Grove Pharmaceuticals Inc. and Wockhardt USA LLC.
1 min read11 Jul 2025The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared